Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Recommendations for a brief international cognitive assessment for multiple sclerosis].
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
EMD Serono Joins ACP to Launch OPT-UP Study
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
ECTRIMS 2015
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study.
Mycophenolate mofetil in the treatment of multiple sclerosis: A preliminary report.
T(H)17 cytokines in autoimmune neuro-inflammation.
Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis.
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
The natural history of primary progressive MS in British Columbia, Canada.
Transfer of interferon β-1a into human breastmilk.
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
MS Research Roundup: January 29, 2014
Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis.
ACTRIMS-ECTRIMS 2014 -- Day 1, afternoon
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
MS Research Roundup: January 31, 2014
Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.
Neuroprotective effects of testosterone treatment in men with multiple sclerosis.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Demyelination of the hippocampus is prominent in the cuprizone model.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.

Pages